Philadelphia, PANCT06092814Now EnrollingIRB Ready

Stroke Clinical Trial in Philadelphia, PA

Access cutting-edge stroke treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by University of Pennsylvania

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access stroke specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related stroke treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this stroke clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Stroke Study in Philadelphia

The goal of this study is to see if transcranial alternating current stimulation (tACS) can be used to enhance language abilities in people with post-stroke aphasia. Participants will receive real and sham tACS in conjunction with various language tests. Researchers will compare the post-stroke aphasia group with aged matched controls to see if brain response to tACS differs between groups.

Sponsor: University of Pennsylvania

Who Can Participate

Inclusion Criteria

for Persons with Aphasia:
Presence of aphasia
Suffered a single, left hemisphere stroke
Stroke ≥6 months old (chronic) at the time of enrollment Inclusion Criteria for Healthy Controls:
Right-handedness
Must be able to understand the nature of the study, and give informed consent

Exclusion Criteria

for Persons with Aphasia:
Inability to understand the nature of the study
Marked naming impairment
Impaired non-verbal, conceptual processing
History of significant medical or neurological disorder (other than stroke)
History of significant or poorly controlled psychiatric disorders
Current abuse of alcohol or drugs, prescription or otherwise
Nursing a child, pregnancy, or intent to become pregnant during the study
Clinically significant hearing loss
Contraindications to tACS
Contraindications to MRI Exclusion Criteria for Healthy Controls
Diagnosis of a neurodegenerative disease or clinically significant cognitive complaint
Any unrelated neurologic or physical condition that impairs communication ability
History of unrelated neurological conditions including but not limited to traumatic brain injury, stroke, or small vessel disease that has resulted in a neurologic deficit
Any additional neurological condition that would likely reduce the safety of study participation, including central nervous system (CNS) vasculitis, intracranial tumor, intracranial aneurysm, multiple sclerosis or arteriovenous malformations
A medically unstable cardiopulmonary or metabolic disorder
Terminal illness associated with survival \<12 months
Major active psychiatric illness that may interfere with required study procedures or treatments as determined by the enrolling physician
Current abuse of alcohol or drugs, prescription or otherwise
Contraindications to tACS
Contraindications to MRI

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT06092814) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Stroke Treatment Options in Philadelphia, PA

If you're searching for stroke treatment options in Philadelphia, PA, this clinical trial (NCT06092814) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all stroke clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Philadelphia, PA

See all stroke clinical trials recruiting in Philadelphia — not just this study.

Browse Stroke Trials in Philadelphia →

Browse More Trials by Condition

Stroke TrialsAll Conditions →

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA